Riana Jumamil

Internal Medicine clinician in Newark, New Jersey — also lists obesity medicine in the CMS registry.

Practice Details

Address
90 Bergen St Rm 2100
Newark, NJ 07103
Geocoded location: 40.7425, -74.1912
Taxonomy
Internal Medicine
Credential
MD MPH
NPPES Enumeration
Listed with NPPES since 2020
Sole Proprietor
Yes
Provider Gender (NPPES)
Female
NPPES Record Updated
September 2025

Specialty taxonomies on file (2)

  • Obesity Medicine
    Preventive Medicine, Obesity Medicine
  • Internal Medicine
    Primary

All specialty taxonomies this NPI reports in the CMS National Provider registry. A taxonomy on file reflects a self-reported designation, not confirmation of current services.

About This Clinician

Riana Jumamil is an Internal Medicine clinician in Newark whose NPPES record also lists an obesity-medicine or bariatric-medicine taxonomy as a secondary specialty. Primary-care and family-medicine clinicians who carry this secondary designation are among those most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices — call ahead to confirm.

Locally, this is 1 of 317 Internal Medicine practices in Newark carrying this exact taxonomy in our directory.

What to expect at an Internal Medicine visit

Internal-medicine practices manage adult and often complex chronic conditions. A GLP-1-related visit commonly involves:

  • A review of chronic conditions, medications, and cardiovascular/metabolic risk.
  • Baseline labs (A1c, metabolic panel, lipids) to guide treatment.
  • A discussion of GLP-1 options for diabetes and/or weight management.
  • A plan for follow-up monitoring and dose adjustment.

This is general guidance for internal medicine practices, not a description of Riana Jumamil's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 973-972-2343.

GLP-1 access in Newark, New Jersey

Adult obesity rate
28.7%
#42 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$224/mo
Typical New Jersey telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
New Jersey Medicaid, obesity indication

About 28.7% of New Jersey adults have obesity (BMI 30+), ranking the state #42 of 50 (CDC BRFSS). Our directory currently lists 31 GLP-1-relevant clinics in Newark. If a cash-pay route makes more sense, compounded semaglutide through New Jersey telehealth averages about $224/mo — well below brand-name Wegovy or Zepbound.

Explore more New Jersey options on the best New Jersey GLP-1 providers page, browse every Newark listing in the Newark clinic directory, or read the New Jersey Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Newark

Other Newark listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to New Jersey addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured New Jersey telehealth partners:

Featured Partners · Newark

Featured GLP-1 providers serving Newark

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Newark options on the Newark clinic directory, our Newark GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Newark obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Riana Jumamil's specialty taxonomy but not the specific medications it prescribes or its current service menu. Riana Jumamil is listed under Internal Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 973-972-2343 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Riana Jumamil's primary specialty on file is Internal Medicine, with obesity medicine listed as a secondary taxonomy. Generalist clinicians who carry that secondary designation are among those who commonly manage GLP-1 prescribing, though the registry does not confirm current services.
Riana Jumamil is located at 90 Bergen St Rm 2100, Newark, NJ 07103. The phone number listed in the registry is 973-972-2343. Its full record is public in the CMS National Provider registry under NPI 1215565213.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Riana Jumamil is currently accepting new patients. Call the practice at 973-972-2343 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.